Summary of Significant Accounting Policies - Additional Information (Detail) - Related Party [Domain] - Short-Term Debt, Type [Domain] - Equity Component [Domain] - USD ($)	1 Months Ended	3 Months Ended		12 Months Ended
	Mar. 28, 2014	Jun. 30, 2015	Jun. 30, 2014	Mar. 31, 2015	Dec. 31, 2014
Summary Of Significant Accounting Policies [Line Items]
Expected term	7 years
Risk free interest rate	2.31%
Expected volatility rate	71.40%
Health Care Organization, Patient Service Revenue		$ 20,000
Financial Liabilities Fair Value Disclosure		$ 2,800,572		$ 2,586,854
Percentage of Interest Rate for Certificates		0.15%
Gain (Loss) on Derivative Instruments, Net, Pretax		$ (213,718)	$ (30,005)
Warrant Liability
Summary Of Significant Accounting Policies [Line Items]
Expected term		5 years 8 months 12 days		6 years
Risk free interest rate		1.83%		1.53%
Expected volatility rate		57.60%		57.40%
Expected dividend rate		0.00%		0.00%
Share Price		$ 6.90		$ 5.00
Percentage For Down round financing		100.00%		100.00%
Financial Liabilities Fair Value Disclosure		$ 2,308,620		$ 2,144,496
Conversion Feature Liability
Summary Of Significant Accounting Policies [Line Items]
Expected term		3 years 8 months 12 days		4 years
Risk free interest rate		1.30%		1.10%
Expected volatility rate		48.60%		47.60%
Expected dividend rate		0.00%		0.00%
Share Price		$ 6.90		$ 5.00
Percentage For Down round financing		100.00%		100.00%
Debt Instrument, Interest Rate, Stated Percentage		8.00%		8.00%
Debt Instrument, Convertible, Conversion Price		$ 10.00		$ 10.00
Financial Liabilities Fair Value Disclosure		$ 491,952		$ 442,358
Maximum
Summary Of Significant Accounting Policies [Line Items]
Management agreement, initial term		20 years
Minimum
Summary Of Significant Accounting Policies [Line Items]
Management agreement, initial term		10 years
ApolloMed ACO
Summary Of Significant Accounting Policies [Line Items]
Benchmark Expenditure					$ 3,900,000
ApolloMed Palliative
Summary Of Significant Accounting Policies [Line Items]
Business Combination, Consideration Transferred		$ 586,111